ADALIMUMAB THERAPY FOR INFLIXIMAB FAILURES IN CROHN'S DISEASE. A SINGLE-CENTRE UK EXPERIENCE

被引：0
|
作者：
Sprakes, M. B. [1 ]
Ford, A. C. [1 ]
Warren, L. [1 ]
Greer, D. [1 ]
Donnellan, C. F. [1 ]
Jennings, J. S. R. [1 ]
Everett, S. M. [1 ]
Hamlin, P. J. [1 ]
机构：
[1] Leeds Gen Infirm, Dept Gastroenterol, Leeds, W Yorkshire, England
来源：
GUT | 2010年 / 59卷
关键词：
D O I：
10.1136/gut.2009.208967h
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A99 / A100
页数：2
相关论文
共 50 条
  • [21] Adalimumab Therapy for Patients With Crohn's Disease Who Are Unresponsive to or Intolerant of Infliximab
    Shafran, I
    Burgunder, P.
    Fakih, A.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S44 - S44
  • [22] A retrospective comparison of infliximab versus adalimumab as induction therapy for crohn's disease
    Varma, P.
    Huang, C.
    Paul, E.
    Headon, B.
    Sparrow, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 108 - 109
  • [23] Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience
    Sprakes, Michael B.
    Hamlin, P. John
    Warren, Lisa
    Greer, Dan
    Ford, Alexander C.
    JOURNAL OF CROHNS & COLITIS, 2011, 5 (04): : 324 - 331
  • [24] Single-centre experience with Mondor's disease: Clinical presentation, therapy and outcome
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 82 - 82
  • [25] Population pharmacokinetics of single dose infliximab in patients with Crohn's disease.
    Fasanmade, AA
    Zhu, YW
    Wagner, C
    Pendley, C
    Davis, HM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P66 - P66
  • [26] Loss of response of anti-TNF in Crohn's disease patients single-centre experience
    Atanassova, A.
    Georgieva, A. C.
    Mirchev, M.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S434 - S434
  • [27] ECONOMIC EVALUATION OF INFLIXIMAB AND ADALIMUMAB FOR CROHN'S DISEASE
    Hughes, D. A.
    Kikuchi, T.
    Bodger, K.
    VALUE IN HEALTH, 2009, 12 (03) : A59 - A59
  • [28] Efficacy of infliximab therapy in pediatric patients with refractory Crohn's disease.
    Fleming, ZI
    Gremse, DA
    Crissinger, KD
    JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (01) : S269 - S269
  • [29] The efficacy of infliximab therapy on growth parameters in pediatric Crohn's disease.
    Varier, R.
    Bass, J.
    Bracken, J.
    Drews, A.
    San Pablo, W.
    Friesen, C.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S65 - S65
  • [30] Infliximab vs. Adalimumab for Crohn's disease
    Mulani, P.
    Chao, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (10) : 1265 - 1266
12345